Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,896 | -110,776 | -85,670 | -59,675 | -36,969 |
| Depreciation Amortization | 1,791 | 8,201 | 6,368 | 4,538 | 2,433 |
| Accounts receivable | 0 | 31 | 31 | 31 | 31 |
| Accounts payable and accrued liabilities | -2,949 | 4,811 | 1,292 | 766 | 299 |
| Other Working Capital | -4,660 | 6,571 | 3,440 | -3,611 | -159 |
| Other Operating Activity | 10,367 | 17,857 | 20,288 | 16,707 | 15,724 |
| Operating Cash Flow | $-27,347 | $-73,305 | $-54,251 | $-41,244 | $-18,641 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 2,107 | 2,107 | 2,107 | N/A |
| PPE Investments | -391 | -2,280 | -2,130 | -1,637 | -1,152 |
| Investing Cash Flow | $-391 | $-173 | $-23 | $470 | $-1,152 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 39,377 | 39,377 | 7,877 | N/A |
| Debt Repayment | -603 | -33,756 | -33,168 | -1,091 | -528 |
| Common Stock Issued | 43,398 | 566 | 313 | 214 | 119 |
| Other Financing Activity | 0 | -1,680 | -1,680 | -1,394 | 0 |
| Financing Cash Flow | $62,795 | $4,507 | $4,842 | $5,606 | $-409 |
| Beginning Cash Position | 80,801 | 149,772 | 149,772 | 149,772 | 149,772 |
| End Cash Position | 115,858 | 80,801 | 100,340 | 114,604 | 129,570 |
| Net Cash Flow | $35,057 | $-68,971 | $-49,432 | $-35,168 | $-20,202 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,347 | -73,305 | -54,251 | -41,244 | -18,641 |
| Capital Expenditure | -391 | -2,280 | -2,130 | -1,637 | -1,152 |
| Free Cash Flow | -27,738 | -75,585 | -56,381 | -42,881 | -19,793 |